|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net: | |||||
| Interest income, net | |||||
| Foreign currency exchange gain | |||||
| Tax credit income | |||||
| Loss on extinguishment of debt | |||||
| Total other income, net | |||||
| Net loss | |||||
| Net loss per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average common shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
| Other comprehensive income (loss): | |||||
| Gain (loss) on foreign currency translation | |||||
| Unrealized gain (loss) on short-term investments | |||||
| Total comprehensive loss | |||||
Loading...